Yao Hermann, Ekou Arnaud, Hadéou Aurore, N'Djessan Jean-Jacques, Kouamé Isabelle, N'Guetta Roland
Intensive Care Unit, Abidjan Heart Institute, 01 BPV 206 Abidjan, Abidjan, Côte d'Ivoire.
BMC Cardiovasc Disord. 2019 Mar 20;19(1):65. doi: 10.1186/s12872-019-1043-1.
Major in-hospital mortality rate in patients with ST-segment Elevation Myocardial Infarction (STEMI) in Sub-Saharan Africa has been reported. Data on follow-up in these patients with STEMI are scarce. We aimed to assess medium and long-term prognosis in patients with STEMI admitted to Abidjan Heart Institute.
Prospective cohort study including 260 patients admitted for STEMI to Abidjan Heart Institute, from January 1, 2012 to December 31, 2015. We compared mortality and nonfatal cardiovascular complications in revascularized and non-revascularized groups. Survival curve was generated with the Kaplan-Meier method. Predictors of mortality after STEMI were determined by multivariable Cox regression.
Of the 260 patients followed up on a median period of 39 months [28-68 months], 94 patients (36.1%) were revascularized and 166 (63.8%) were non-revascularized. Crude all-cause mortality was 10.4%. It was significantly higher in non-revascularized patients (p = 0.04). There was no difference in the occurrence of nonfatal cardiovascular complications in the 2 groups. In multivariable Cox regression, age ≥ 70 years, female gender and heart failure were the predictive factors for death after adjustment.
STEMI remains an important cause of mortality in our practice. Healthcare policies should be developed to improve patient care and long-term outcomes.
撒哈拉以南非洲地区ST段抬高型心肌梗死(STEMI)患者的院内主要死亡率已有报道。关于这些STEMI患者随访的数据却很稀少。我们旨在评估阿比让心脏研究所收治的STEMI患者的中长期预后。
前瞻性队列研究,纳入2012年1月1日至2015年12月31日期间因STEMI入住阿比让心脏研究所的260例患者。我们比较了血管重建组和非血管重建组的死亡率和非致死性心血管并发症。采用Kaplan-Meier法生成生存曲线。通过多变量Cox回归确定STEMI后死亡的预测因素。
在中位随访期为39个月[28 - 68个月]的260例患者中,94例(36.1%)接受了血管重建,166例(63.8%)未接受血管重建。粗全因死亡率为10.4%。未接受血管重建的患者死亡率显著更高(p = 0.04)。两组非致死性心血管并发症的发生率无差异。在多变量Cox回归中,年龄≥70岁、女性性别和心力衰竭是调整后死亡的预测因素。
在我们的实践中,STEMI仍然是一个重要的死亡原因。应制定医疗政策以改善患者护理和长期预后。